Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: ‘After gender pay gap, need push for disability pay gap reporting’

With the UK government mandating a gender pay gap reporting by corporates and amid calls for an ethnicity pay gap report, there is an urgent need to make a case for setting up disability pay gap records, said Jay Muthu, director of Organization and People Capability at Entain Group.

“I think we need to kind of lobby the government to make that happen, but unfortunately a lot of disability organisations are still fighting for the basic rights,” Muthu said during a panel discussion on Disability Inclusion In The Workplace held during the Pharmacy Business Diversity Conference on Thursday (December 9).


The session, moderated by the conference chair and BBC presenter Clive Myrie, also had Kate Nash OBE, founder and chief executive officer of Purple Space, which is the world’s only professional development membership hub for disability employee resource groups.

Muthu said: “The challenges are from both sides. There is obviously the societal stigma (attached with disability). There are corporations not being aware and not wanting to educate themselves, and then there is the government not really implementing the right kind of mechanisms to make it happen.

“Government feels disability is a charity case, rather than a talent case.”

Talking about faults in the corporates’ hiring process, he said firms should change their attitude towards employing disabled people.

He said around 15 to 18 per cent of the world’s population were disabled and about 60 per cent of that are unemployed.

“Today, we are hearing terms like the great resignation or the great quit, where there is a huge talent crunch,” while on the other hand “there is probably a huge group of people who could fill in the gaps that talent crunch is creating,” he added.

However, hiring managers are still cagey about recruiting people with disabilities for which they cite multiple reasons such as additional cost to make the workplace conducive for disabled employees, lower performance level by them, etc.

Negating the popular opinions of corporates, he said: “Most people with disabilities, when you give them an opportunity, they will kind of grab it with all their hands and do a good job of it, isn't it and that's true with every minority population.”

Seconding the thoughts shared by Muthu, Nash said: “I believe that there are some halftones in the system.”

She added that reporting data on disability is going to be a big challenge “simply because of some of the stigma that surrounds the experience of disability.”

Nash said: “It can take a very long time for someone with a disability or ill health to share their story of disability is often called a declaration of disability or disclosure, and it often takes people a long time to understand that their experience their hearing experience is the same as that which is enshrined in law.”

She advocated that corporate boards should think deeply about the instruments or measures needed to support their people.

Muthu added that discussing and initiating positive steps for inclusion of disabled people in the workplace is even more more important now because the Covid-19 pandemic has pushed disabled people around five steps backward.

He said: “We're really hoping that the government starts waking up and thinking that we need to address the talent problem through multiple channels and disabled talent to one of those channels.”

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less